Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2002
12/12/2002WO2002099089A1 Compositions and methods for high-level, large-scale production of recombinant proteins
12/12/2002WO2002099075A2 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099074A2 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099070A2 Compositions and methods for high-level, large-scale production of recombinant proteins
12/12/2002WO2002099067A2 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
12/12/2002WO2002099060A2 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099040A2 Igs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098920A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002WO2002098905A2 Enzymatic coupling of l-phenylalanine methyl ester and n-benzyloxycarbonyl-l-aspartic acid in a continuous or fed-batch process
12/12/2002WO2002098899A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098897A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
12/12/2002WO2002098369A2 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002WO2002098368A2 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002WO2002098356A2 Ppp2cs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098346A2 Method and pharmaceutical composition for the treatment of multiple sclerosis
12/12/2002WO2002088302A9 Method for secreting proteins by bacteria, leader sequences and vectors for carrying out said method
12/12/2002WO2002086058A9 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
12/12/2002WO2002074798A3 The genome of a bifidobacterium
12/12/2002WO2002072015A3 M cell directed vaccines
12/12/2002WO2002070552A3 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
12/12/2002WO2002067848A3 PEPTIDES FROM THE 16/6id ANTIBODY FOR TREATING SLE
12/12/2002WO2002064161A3 Method and compositions for immunization with the pseudomonas v antigen
12/12/2002WO2002062972A3 Hybridoma cell line g250 and its use for producing monoclonal antibodies
12/12/2002WO2002062843A3 Modified erythropoietin (epo) with reduced immunogenicity
12/12/2002WO2002053723A3 Degradation and detection of tse infectivity
12/12/2002WO2002046404A3 Schizophrenia-related voltage-gated ion channel gene and protein
12/12/2002WO2002044718A3 S.aureus protein staau r2, gene encoding it and uses thereof
12/12/2002WO2002030958A3 Casein peptide fragments with growth-influencing activity on cell cultures
12/12/2002WO2002024749A3 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/12/2002WO2002018557A3 Human kinases
12/12/2002WO2002008292A3 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
12/12/2002WO2001093983A9 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/12/2002WO2001038360A9 Novel hcv non-structural polypeptide
12/12/2002WO2001022864A9 Sequences characteristic of bladder cancer
12/12/2002US20020188109 Expression vector for use transformation of yeast cells
12/12/2002US20020187992 Prodrugs via acylation with cinnamate
12/12/2002US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002US20020187930 Substances and their uses
12/12/2002US20020187541 Method for production of alpha-amylase in recombinant bacillus
12/12/2002US20020187535 Enzymatic polypeptide for use in the treatment of emphysema, adult respiratory distress syndrome and psoriasis
12/12/2002US20020187523 Extracellular signaling molecules
12/12/2002US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation
12/12/2002US20020187472 Nucleotide sequences coding protein for use in the treatment of cancer
12/12/2002US20020187466 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection
12/12/2002US20020187163 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine
12/12/2002US20020187157 Administering an amyloidogenic polypeptide or subsequence thereof to induces production of antibodies against the amyloidogenic polypeptide; treatment of Alzheimer's disease
12/12/2002US20020187155 Ringworm vaccine
12/12/2002US20020187141 Composites that bind a multidrug transporter protein and an antigen associated with a tumor or infectious agent; determination whether the failure of traditional chemotherapy is due to multidrug resistant tumor cells
12/12/2002US20020187140 Two novel human cathepsin proteins
12/12/2002US20020187135 Methods for inducing antigen-specific t cell tolerance
12/12/2002CA2463310A1 Compositions and methods for high-level, large-scale production of recombinant proteins
12/12/2002CA2451765A1 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
12/12/2002CA2449670A1 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002CA2449663A1 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002CA2449482A1 Chds as modifiers of the p53 pathway and methods of use
12/12/2002CA2449281A1 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002CA2449275A1 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002CA2449136A1 Igs as modifiers of the p53 pathway and methods of use
12/12/2002CA2448606A1 Nucleic acid-associated proteins
12/12/2002CA2448427A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002CA2448282A1 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002CA2447695A1 Modified antibodies to prostate-specific membrane antigen and uses thereof
12/12/2002CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof
12/11/2002EP1264896A1 Enzymatic coupling of L-phenylalanine methyl ester and N-benzyloxycarbonyl-l-aspartic acid in a continuous or fed-batch process
12/11/2002EP1264890A2 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
12/11/2002EP1264889A1 Chicken leukemia inhibitory factor (LIF) and the gene thereof
12/11/2002EP1264886A1 Improved promoters and utilization thereof
12/11/2002EP1264885A1 Antibody library
12/11/2002EP1264881A2 Engineering nicking endonucleases from type IIs restriction endonucleases
12/11/2002EP1263981A2 Matrix reactor and a method for producing products in said reactor
12/11/2002EP1263968A1 Beta 1, 2-xylosyltransferase-gene from arabidopsis
12/11/2002EP1263963A2 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
12/11/2002EP1263960A2 Anti-tissue factor antibodies with enhanced anticoagulant potency
12/11/2002EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
12/11/2002EP1263957A2 Human lipid binding protein 1
12/11/2002EP1263956A2 Human genes and gene expression products
12/11/2002EP1263955A2 Polypeptides and nucleic acids encoding same
12/11/2002EP1263954A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/11/2002EP1263948A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2002EP1263944A2 Nucleic acids, proteins, and antibodies
12/11/2002EP1263938A1 Udp-galactose: beta-d-galactose-r 4-alpha-d-galactosyltransferase, alpha4gal-t1
12/11/2002EP1263936A1 Altered strain of the modified vaccinia virus ankara (mva)
12/11/2002EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10
12/11/2002EP1263790A1 Monoclonal antibodies to the human ldl receptor, their production and use
12/11/2002EP1263787A2 G-protein coupled receptors
12/11/2002EP1263784A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
12/11/2002EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer
12/11/2002EP1263767A2 Beta netrin and uses thereof
12/11/2002EP1263766A1 Adam polynucleotides, polypeptides, and antibodies
12/11/2002EP1263452A2 Methods and compositions for generating angiostatin
12/11/2002EP0802985B1 Cell cycle regulated repressor and dna element
12/11/2002EP0591431B1 Hepatitis c virus (hcv) polypeptides
12/11/2002CN1384886A Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit
12/11/2002CN1384881A Compositions and methods for non-targeted activation of endogenous genes
12/11/2002CN1384878A IREN protein, its preparation and use
12/11/2002CN1384205A Large-scale protein process of recombinant human liver cell growth factor rhHGF
12/11/2002CN1384204A Production process of active casein polypeptide with coarse cheese
12/11/2002CN1384195A Application of bollowrm granule virus synergy protein
12/11/2002CN1384114A Growth promoting factor and its prepn and use
1 ... 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 ... 1125